These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 31930150

  • 1. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 2. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 3. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD, Stump KL, Wallace NH, Dobrzanski P, Serdikoff C, Gingrich DE, Dugan BJ, Angeles TS, Albom MS, Mason JL, Ator MA, Dorsey BD, Ruggeri BA, Seavey MM.
    J Immunol; 2011 Oct 01; 187(7):3840-53. PubMed ID: 21880982
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
    Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z, Yang X, Zhu F, He P, Tang W, Zuo J.
    Cell Mol Immunol; 2016 May 01; 13(3):379-90. PubMed ID: 25942599
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus.
    Peng L, Wang P, Xu X, Chen D, Xu F, Yang F, Yang S, Xia H, Liu ZH, Qin W.
    Lupus Sci Med; 2024 Jun 21; 11(1):. PubMed ID: 38906550
    [Abstract] [Full Text] [Related]

  • 6. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S.
    Nephron; 1993 Jun 21; 64(3):471-5. PubMed ID: 7688103
    [Abstract] [Full Text] [Related]

  • 7. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
    Ji J, Xu J, Li F, Li X, Gong W, Song Y, Dou H, Hou Y.
    Acta Biochim Biophys Sin (Shanghai); 2016 May 21; 48(5):411-9. PubMed ID: 27121231
    [Abstract] [Full Text] [Related]

  • 8. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
    Keil A, Hall SR, Körner M, Herrmann M, Schmid RA, Frese S.
    Arthritis Res Ther; 2016 Oct 22; 18(1):243. PubMed ID: 27770825
    [Abstract] [Full Text] [Related]

  • 9. Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice.
    Hong SM, Lee J, Jang SG, Song Y, Kim M, Lee J, Cho ML, Kwok SK, Park SH.
    Int J Mol Sci; 2020 Nov 11; 21(22):. PubMed ID: 33187196
    [Abstract] [Full Text] [Related]

  • 10. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 11; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 11. 4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice.
    Kulkarni OP, Sayyed SG, Kantner C, Ryu M, Schnurr M, Sárdy M, Leban J, Jankowsky R, Ammendola A, Doblhofer R, Anders HJ.
    Am J Pathol; 2010 Jun 11; 176(6):2840-7. PubMed ID: 20413687
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM, He Y, Farkash EA, Schonfeld M, Tsou PS, Sawalha AH.
    Arthritis Rheumatol; 2019 Oct 11; 71(10):1681-1690. PubMed ID: 31106974
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep 11; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 14. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.
    Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR.
    J Am Soc Nephrol; 2019 Feb 11; 30(2):244-259. PubMed ID: 30622154
    [Abstract] [Full Text] [Related]

  • 15. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.
    Clin Immunol; 2017 Dec 11; 185():100-108. PubMed ID: 27570219
    [Abstract] [Full Text] [Related]

  • 16. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 11; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 17. Amiselimod (MT-1303), a novel sphingosine 1-phosphate receptor-1 functional antagonist, inhibits progress of chronic colitis induced by transfer of CD4+CD45RBhigh T cells.
    Shimano K, Maeda Y, Kataoka H, Murase M, Mochizuki S, Utsumi H, Oshita K, Sugahara K.
    PLoS One; 2019 Apr 11; 14(12):e0226154. PubMed ID: 31805144
    [Abstract] [Full Text] [Related]

  • 18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice.
    Fujii T, Okada M, Fujita Y, Sato T, Tanaka M, Usui T, Umehara H, Mimori T.
    J Autoimmun; 2009 Sep 01; 33(2):125-34. PubMed ID: 19596182
    [Abstract] [Full Text] [Related]

  • 20. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
    Wiener A, Schippers A, Wagner N, Tacke F, Ostendorf T, Honke N, Tenbrock K, Ohl K.
    Clin Exp Immunol; 2016 Jul 01; 185(1):22-32. PubMed ID: 26990531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.